SC 13G | 2020-06-11 | ACACIA RESEARCH CORP | Theravance Biopharma, Inc. | 0 | 0.0% | EDGAR |
SC 13G/A | 2020-03-09 | BlackRock Inc. | Theravance Biopharma, Inc. | 8,682,679 | 13.9% | EDGAR |
SC 13D/A | 2020-02-27 | GLAXOSMITHKLINE PLC | Theravance Biopharma, Inc. | 9,644,808 | 15.5% | EDGAR |
SC 13D/A | 2020-02-18 | GLAXOSMITHKLINE PLC | Theravance Biopharma, Inc. | 9,644,808 | 15.5% | EDGAR |
SC 13G/A | 2020-02-12 | VANGUARD GROUP INC | Theravance Biopharma, Inc. | 4,003,602 | 7.0% | EDGAR |
SC 13G/A | 2020-02-07 | FMR LLC | Theravance Biopharma, Inc. | 8,524,173 | 15.0% | EDGAR |
SC 13G/A | 2020-02-06 | BlackRock Inc. | Theravance Biopharma, Inc. | 3,829,079 | 6.7% | EDGAR |
SC 13G | 2020-01-28 | WELLINGTON MANAGEMENT GROUP LLP | Theravance Biopharma, Inc. | 3,177,537 | 5.6% | EDGAR |
SC 13G/A | 2019-11-08 | Woodford Investment Management Ltd | Theravance Biopharma, Inc. | 429,770 | 0.8% | EDGAR |
SC 13G | 2019-10-29 | Link Fund Solutions Ltd | Theravance Biopharma, Inc. | 5,251,349 | 9.3% | EDGAR |
SC 13D/A | 2019-04-18 | GLAXOSMITHKLINE PLC | Theravance Biopharma, Inc. | 9,644,808 | 17.4% | EDGAR |
SC 13G/A | 2019-02-14 | LF Woodford Equity Income Fund | Theravance Biopharma, Inc. | 10,592,189 | 19.1% | EDGAR |
SC 13G/A | 2019-02-14 | Woodford Investment Management Ltd | Theravance Biopharma, Inc. | 12,316,529 | 22.2% | EDGAR |
SC 13G/A | 2019-02-13 | FMR LLC | Theravance Biopharma, Inc. | 8,336,726 | 15.0% | EDGAR |
SC 13G/A | 2019-02-12 | VANGUARD GROUP INC | Theravance Biopharma, Inc. | 3,980,060 | 7.2% | EDGAR |
SC 13G/A | 2019-02-06 | BlackRock Inc. | Theravance Biopharma, Inc. | 3,863,076 | 7.0% | EDGAR |
SC 13G/A | 2018-02-13 | FMR LLC | Theravance Biopharma, Inc. | 8,139,620 | 15.0% | EDGAR |
SC 13G/A | 2018-02-13 | BAUPOST GROUP LLC/MA | Theravance Biopharma, Inc. | 10,179,996 | 18.5% | EDGAR |
SC 13G/A | 2018-02-13 | CF Woodford Equity Income Fund | Theravance Biopharma, Inc. | 8,114,946 | 15.0% | EDGAR |
SC 13G/A | 2018-02-13 | Woodford Investment Management Ltd | Theravance Biopharma, Inc. | 10,747,108 | 19.9% | EDGAR |